L de Leij
- Oncology top 10%
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 5%
- Immunology top 10%
- Epidemiology
- Co-authors
- S PoppemaT H ThéPieter E. PostmusB. J. KroesenWijnand HelfrichHenk H. BerendsenA. ter HaarGrietje Molema
- Topics
- Monoclonal and Polyclonal Antibodies Research (15 papers)T-cell and B-cell Immunology (6 papers)CAR-T cell therapy research (5 papers)
- Partner nations
- NetherlandsUnited StatesMexico
In The Last Decade
L de Leij
26 papers receiving 662 citations
Peers
Comparison fields: 5 of 66
- Oncology 293
- Molecular Biology 274
- Radiology, Nuclear Medicine and Imaging 241
- Immunology 224
- Epidemiology 164
Countries citing papers authored by L de Leij
This map shows the geographic impact of L de Leij's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L de Leij with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L de Leij more than expected).
Fields of papers citing papers by L de Leij
This network shows the impact of papers produced by L de Leij. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L de Leij. The network helps show where L de Leij may publish in the future.
Co-authorship network of co-authors of L de Leij
This figure shows the co-authorship network connecting the top 25 collaborators of L de Leij. A scholar is included among the top collaborators of L de Leij based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L de Leij. L de Leij is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | Bi-specific antibody therapy for the treatment of cancer. | 40 |
| 3 | 47 | |
| 4 | 11 | |
| 5 | 1 | |
| 6 | 9 | |
| 7 | 4 | |
| 8 | 9 | |
| 9 | 10 | |
| 10 | 1 | |
| 11 | 29 | |
| 12 | Bispecific antibody-mediated target cell-specific costimulation of resting T cells via CD5 and CD28. | 31 |
| 13 | 67 | |
| 14 | 74 | |
| 15 | 8 | |
| 16 | 6 | |
| 17 | 12 | |
| 18 | 99 | |
| 19 | 30 | |
| 20 | In situ analysis of the mononuclear cell infiltrate in primary malignant melanoma of the skin. | 72 |
About L de Leij
L de Leij is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Oncology, having authored 26 papers that have together received 707 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (15 papers), T-cell and B-cell Immunology (6 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Oncology (293 citations), Immunology (224 citations) and Radiology, Nuclear Medicine and Imaging (241 citations). L de Leij has collaborated with scholars based in Netherlands, United States and Mexico. Frequent co-authors include S Poppema, T H Thé, Pieter E. Postmus, B. J. Kroesen, Wijnand Helfrich, Henk H. Berendsen, A. ter Haar, Grietje Molema, Hao Chung The and Adriana Boes. Their work appears in journals such as Journal of Clinical Oncology, Advanced Drug Delivery Reviews and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.